Panacea Biotec (BOM:531349) Net Issuance of Preferred Stock : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Panacea Biotec's net issuance of preferred for the three months ended in Mar. 2024 was ₹0 Mil. The number is 0, which means that Panacea Biotec has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Panacea Biotec's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Panacea Biotec Net Issuance of Preferred Stock Historical Data

The historical data trend for Panacea Biotec's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Net Issuance of Preferred Stock Chart

Panacea Biotec Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Panacea Biotec Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Panacea Biotec Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Panacea Biotec Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacea Biotec (BOM:531349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

PANACEABIO:India

Address

Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044

Website

https://www.panaceabiotec.com

Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (BOM:531349) Headlines

No Headlines